Loop diuretic strategies in patients with acute decompensated heart failure: A meta-analysis of randomized controlled trials

Journal of Critical Care

Volumn 29, Issue 1, 2014, Pages 2-9

  Wu, Mei Yi ^a   Chang, Nen Chung ^b   Su, Chien Ling ^a,c   Hsu, Yung Ho ^a   Chen, Tzen Wen ^c   Lin, Yuh Feng ^a,d   Wu, Chih Hsiung ^a   Tam, Ka Wai ^a,b,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Diuretics; Furosemide; Heart failure; Meta analysis

Indexed keywords

CREATININE; FUROSEMIDE; LOOP DIURETIC AGENT; TORASEMIDE;

ACUTE HEART FAILURE; ARTICLE; CARDIOVASCULAR MORTALITY; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; ELECTROLYTE DISTURBANCE; HEARING IMPAIRMENT; HOSPITALIZATION; HUMAN; INCIDENCE; LOADING DRUG DOSE; META ANALYSIS; OTOTOXICITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TINNITUS; URINE VOLUME; WEIGHT REDUCTION;

DIURETICS; FUROSEMIDE; HEART FAILURE; META-ANALYSIS;

ACUTE DISEASE; CRITICAL CARE; FUROSEMIDE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; URINALYSIS; WEIGHT LOSS;

EID: 84890167946     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.10.009     Document Type: Article

References (39)

1. Munger M.A. Management of acute decompensated heart failure: treatment controversy, and future directions. Pharmacotherapy 2006, 26:131S-138S.
2. Peacock W.F., Costanzo M.R., De Marco T., Lopatin M., Wynne J., Mills R.M., et al. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology 2009, 113:12-19.
3. Gottlieb S.S., Brater D.C., Thomas I., Havranek E., Bourge R., Goldman S., et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002, 105:1348-1353.
4. Freda B.J., Slawsky M., Mallidi J., Braden G.L. Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics. Am J Kidney Dis 2011, 58:1005-1017.
5. Hutcheon D.E., Mehta D., Romano A. Diuretic action of furosemide. Arch Intern Med 1965, 115:542-546.
6. Aspromonte N., Cruz D.N., Valle R., Bonello M., Tubaro M., Gambaro G., et al. Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure. Expert Opin Drug Metab Toxicol 2011, 7:1049-1063.
7. Michael Felker G. Diuretic management in heart failure. Congest Heart Fail 2010, 16(Suppl 1):S68-S72.
8. Greger R., Wangemann P. Loop diuretics. Ren Physiol 1987, 10:174-183.
9. van Meyel J.J., Smits P., Dormans T., Gerlag P.G., Russel F.G., Gribnau F.W. Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. J Intern Med 1994, 235:329-334.
10. Salvador D.R., Rey N.R., Ramos G.C., Punzalan F.E. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2005, 3:1-25. CD003178.
11. Felker G.M., Lee K.L., Bull D.A., Redfield M.M., Stevenson L.W., Goldsmith S.R., et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011, 364:797-805.
12. Thomson M.R., Nappi J.M., Dunn S.P., Hollis I.B., Rodgers J.E., Van Bakel A.B. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail 2010, 16:188-193.
13. Allen L.A., Turer A.T., Dewald T., Stough W.G., Cotter G., O'Connor C.M. Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure. Am J Cardiol 2010, 105:1794-1797.
14. Higgins JPT SG. Cochrane handbook for systematic reviews of interventions. 5.1.0 (updated March 2011).
15. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009, 62:e1-e34.
16. Hozo S.P., Djulbegovic B., Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005, 5:13-22.
17. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
18. Egger M., Smith G.D., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
19. Ostermann M., Alvarez G., Sharpe M.D., Martin C.M. Frusemide administration in critically ill patients by continuous compared to bolus therapy. Nephron Clin Pract 2007, 107:c70-c76.
20. Licata G., Di Pasquale P., Parrinello G., Cardinale A., Scandurra A., Follone G., et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J 2003, 145:459-466.
21. Costanzo M.R., Guglin M.E., Saltzberg M.T., Jessup M.L., Bart B.A., Teerlink J.R., et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007, 49:675-683.
22. Costanzo M.R., Saltzberg M.T., Jessup M., Teerlink J.R., Sobotka P.A. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Card Fail 2010, 16:277-284.
23. Aaser E., Gullestad L., Tollofsrud S., Lundberg J., Hall C., Djoseland O., et al. Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. Scand J Clin Lab Invest 1997, 57:361-367.
24. Bagatin J., Sardelic S., Gancevic I. Diuretic efficiency of furosemide in continuous intravenous infusion vs. bolus injection in congestive heart failure: results of a pilot study. Pharmaca 1993, 31:279-286.
25. Dormans T.P., van Meyel J.J., Gerlag P.G., Tan Y., Russel F.G., Smits P. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 1996, 28:376-382.
26. Kramer W.G., Smith W.B., Ferguson J., Serpas T., Grant A.G., Black P.K., et al. Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure. J Clin Pharmacol 1996, 36:265-270.
27. Lahav M., Regev A., Ra'anani P., Theodor E. Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest 1992, 102:725-731.
28. Pivac N., Rumboldt Z., Sardelić S., Bagatin J., Polic S., Ljutic D., et al. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. Int J Clin Pharmacol Res 1998, 18:121-128.
29. Schuller D., Lynch J.P., Fine D. Protocol-guided diuretic management: comparison of furosemide by continuous infusion and intermittent bolus. Crit Care Med 1997, 25:1969-1975.
30. Herzog E., Varley C., Kukin M. Pathway for the management of acute heart failure. Crit Pathw Cardiol 2005, 4:37-42.
31. Brater D.C. Diuretic resistance: mechanisms and therapeutic strategies. Cardiology 1994, 84(Suppl 2):57-67.
32. Yelton S.L., Gaylor M.A., Murray K.M. The role of continuous infusion loop diuretics. Ann Pharmacother 1995, 29:1010-1014. [quiz 60-1].
33. Hasselblad V., Gattis Stough W., Shah M.R., Lokhnygina Y., O'Connor C.M., Califf R.M., et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 2007, 9:1064-1069.
34. Wilcox C.S., Mitch W.E., Kelly R.A., Skorecki K., Meyer T.W., Friedman P.A., et al. Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med 1983, 102:450-458.
35. Milionis H.J., Alexandrides G.E., Liberopoulos E.N., Bairaktari E.T., Goudevenos J., Elisaf M.S. Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure. Eur J Heart Fail 2002, 4:167-173.
36. Butler J., Forman D.E., Abraham W.T., Gottlieb S.S., Loh E., Massie B.M., et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004, 147:331-338.
37. Rybak L.P. Pathophysiology of furosemide ototoxicity. J Otolaryngol 1982, 11:127-133.
38. Howard P.A., Dunn M.I. Aggressive diuresis for severe heart failure in the elderly. Chest 2001, 119:807-810.
39. Egger M., Juni P., Bartlett C., Holenstein F., Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess 2003, 7:1-76.